These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 21476148)
41. HIV positive status disclosure among women attending art clinic at Hawassa University Referral Hospital, South Ethiopia. Gari T; Habte D; Markos E East Afr J Public Health; 2010 Mar; 7(1):87-91. PubMed ID: 21413581 [TBL] [Abstract][Full Text] [Related]
42. Perceived Stigma and Fear of Unintended Disclosure are Barriers in Medication Adherence in Adolescents with Perinatal HIV in Botswana: A Qualitative Study. Madiba S; Josiah U Biomed Res Int; 2019; 2019():9623159. PubMed ID: 31886271 [TBL] [Abstract][Full Text] [Related]
43. Pill taking from the perspective of HIV-Infected women who are vulnerable to antiretroviral treatment failure. Stevens PE; Hildebrandt E Qual Health Res; 2009 May; 19(5):593-604. PubMed ID: 19258590 [TBL] [Abstract][Full Text] [Related]
44. [More HIV-positive women are referred to a medication adherence clinic than men]. Schneider MP; Krummenacher I; Bugnon O; Cavassini M Rev Med Suisse; 2010 Jul; 6(257):1455-7. PubMed ID: 20806563 [TBL] [Abstract][Full Text] [Related]
45. A Socio-Ecological Examination of Treatment Access, Uptake and Adherence Issues Encountered By HIV-Positive Women in Rural North-Central Nigeria. Cornelius LJ; Erekaha SC; Okundaye JN; Sam-Agudu NA J Evid Inf Soc Work; 2018; 15(1):38-51. PubMed ID: 29236624 [TBL] [Abstract][Full Text] [Related]
46. Influences on Adherence to Antiretroviral Therapy (ART) in Early-Stage HIV Disease: Qualitative Study from Uganda and South Africa. Ware NC; Wyatt MA; Pisarski EE; Bwana BM; Orrell C; Asiimwe S; Amanyire G; Musinguzi N; Bangsberg DR; Haberer JE; AIDS Behav; 2020 Sep; 24(9):2624-2636. PubMed ID: 32140877 [TBL] [Abstract][Full Text] [Related]
47. Social and economic barriers to adherence among patients at Livingstone General Hospital in Zambia. Moomba K; Van Wyk B Afr J Prim Health Care Fam Med; 2019 Apr; 11(1):e1-e6. PubMed ID: 31038336 [TBL] [Abstract][Full Text] [Related]
48. Barriers and facilitators to patients' adherence to antiretroviral treatment in Zambia: a qualitative study. Sanjobo N; Frich JC; Fretheim A SAHARA J; 2008 Sep; 5(3):136-43. PubMed ID: 18979047 [TBL] [Abstract][Full Text] [Related]
49. Qualitative exploration of the relationship between HIV/AIDS patients' experiences of clinical services and treatment adherence at Maitama District Hospital, Abuja, Nigeria. Audu B; Morgan R; Rutter P AIDS Care; 2014 Feb; 26(2):270-3. PubMed ID: 23875980 [TBL] [Abstract][Full Text] [Related]
50. Factors affecting adherence of antiretroviral treatment among AIDS patients in an Ethiopian tertiary university teaching hospital. Giday A; Shiferaw W Ethiop Med J; 2010 Jul; 48(3):187-94. PubMed ID: 21073079 [TBL] [Abstract][Full Text] [Related]
51. A Mixed Methods Study of Anticipated and Experienced Stigma in Health Care Settings Among Women Living with HIV in the United States. Rice WS; Turan B; Fletcher FE; Nápoles TM; Walcott M; Batchelder A; Kempf MC; Konkle-Parker DJ; Wilson TE; Tien PC; Wingood GM; Neilands TB; Johnson MO; Weiser SD; Turan JM AIDS Patient Care STDS; 2019 Apr; 33(4):184-195. PubMed ID: 30932700 [TBL] [Abstract][Full Text] [Related]
52. "Supposed to make you better but it doesn't really": HIV-positive youths' perceptions of HIV treatment. Veinot TC; Flicker SE; Skinner HA; McClelland A; Saulnier P; Read SE; Goldberg E J Adolesc Health; 2006 Mar; 38(3):261-7. PubMed ID: 16488824 [TBL] [Abstract][Full Text] [Related]
53. Received social support, self-efficacy, and finding benefits in disease as predictors of physical functioning and adherence to antiretroviral therapy. Luszczynska A; Sarkar Y; Knoll N Patient Educ Couns; 2007 Apr; 66(1):37-42. PubMed ID: 17097259 [TBL] [Abstract][Full Text] [Related]
54. Deterrents to HIV-patient initiation of antiretroviral therapy in urban Lusaka, Zambia: a qualitative study. Musheke M; Bond V; Merten S AIDS Patient Care STDS; 2013 Apr; 27(4):231-41. PubMed ID: 23530573 [TBL] [Abstract][Full Text] [Related]
55. Living well with HIV in Nigeria? Stigma and survival challenges preventing optimum benefit from an ART clinic. Aransiola J; Imoyera W; Olowookere S; Zarowsky C Glob Health Promot; 2014 Mar; 21(1):13-22. PubMed ID: 24569837 [TBL] [Abstract][Full Text] [Related]
56. Factors influencing medication adherence beliefs and self-efficacy in persons naive to antiretroviral therapy: a multicenter, cross-sectional study. Reynolds NR; Testa MA; Marc LG; Chesney MA; Neidig JL; Smith SR; Vella S; Robbins GK; AIDS Behav; 2004 Jun; 8(2):141-50. PubMed ID: 15187476 [TBL] [Abstract][Full Text] [Related]
57. Barriers and facilitators to antiretroviral medication adherence among patients with HIV in Chennai, India: a qualitative study. Kumarasamy N; Safren SA; Raminani SR; Pickard R; James R; Krishnan AK; Solomon S; Mayer KH AIDS Patient Care STDS; 2005 Aug; 19(8):526-37. PubMed ID: 16124847 [TBL] [Abstract][Full Text] [Related]
58. "It's Almost Like a Crab-in-a-Barrel Situation": Stigma, Social Support, and Engagement in Care Among Black Men Living With HIV. Quinn K; Dickson-Gomez J; Broaddus M; Kelly JA AIDS Educ Prev; 2018 Apr; 30(2):120-136. PubMed ID: 29688770 [TBL] [Abstract][Full Text] [Related]
59. Motivation for adherence to antiretroviral therapy by transgender people living with hiv - A study in West Bengal, India. Ghosh GK; Biswas S; Ghosh P; Ganguly S; Saha MK Indian J Public Health; 2020 Apr; 64(Supplement):S79-S82. PubMed ID: 32295962 [TBL] [Abstract][Full Text] [Related]
60. Pathways From HIV-Related Stigma to Antiretroviral Therapy Measures in the HIV Care Cascade for Women Living With HIV in Canada. Logie CH; Lacombe-Duncan A; Wang Y; Kaida A; Conway T; Webster K; de Pokomandy A; Loutfy MR; Anema A; Becker D; Brotto L; Carter A; Cardinal C; Colley G; Ding E; Duddy J; Gataric N; Hogg RS; Hosward T; Jabbari S; Jones E; Kestler M; Langlois A; Lima V; Lloyd-Smith E; Medjuck M; Miller C; Money D; Nicholson V; Ogilvie G; Patterson S; Pick N; Roth E; Salters K; Sanchez M; Sas J; Sereda P; Summers M; Tom C; Wang L; Webster K; Zhang W; Abdul-Noor R; Angel J; Barry F; Bauer G; Beaver K; Benoit A; Bertozzi B; Borton S; Bourque T; Brophy J; Burchell A; Carlson A; Cioppa L; Cohen J; Conway T; Cooper C; Cotnam J; Cousineau J; Fraleigh A; Gagnier B; Gasingirwa C; Greene S; Hart T; Islam S; Kaushic C; Kennedy L; Kerr D; Kiboyogo M; Kwaramba G; Leonard L; Lewis J; Logie C; Margolese S; Muchenje M; Ndungʼu M; OʼBrien K; Ouellette C; Powis J; Quan C; Raboud J; Rachlis A; Ralph E; Rourke S; Rueda S; Sandre R; Smaill F; Smith S; Tigere T; Tharao W; Walmsley S; Wobeser W; Yee J; Yudin M; Baril JG; Burke NB; Clément P; Dayle J; Dubuc D; Fernet M; Groleau D; Hot A; Klein M; Martin C; Massie L; Ménard B; OʼBrien N; Otis J; Peltier D; Pierre A; Proulx-Boucher K; Rouleau D; Savoie É; Tremblay C; Trottier B; Trottier S; Tsoukas C; Gahagan J; Hankins C; Masching R; Ogunnaike-Cooke S J Acquir Immune Defic Syndr; 2018 Feb; 77(2):144-153. PubMed ID: 29135650 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]